Update on antifungal therapy.
Fungal pathogens are becoming increasingly important for human and small animal medicine. This article highlights many standards-of-care and new agents for treatment of these pathogens for small animals and people.
Grooters
Amy M
AM
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Skip Bertman Drive, Louisiana State University, Baton Rouge, LA 70803, USA. agrooters@vetmed.lsu.edu
Taboada
Joseph
J
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D054714:Echinocandins; D015725:Fluconazole / Q000627:therapeutic use; D017964:Itraconazole / Q000627:therapeutic use; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy / Q000662:veterinary*; D009281:Naphthalenes / Q000627:therapeutic use; D010455:Peptides; D010456:Peptides, Cyclic; D000077291:Terbinafine
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D009281:Naphthalenes; D010455:Peptides; D010456:Peptides, Cyclic; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D000077336:Caspofungin; D000077291:Terbinafine